Tectonic Therapeutic, Inc.
TECXNext catalyst
TX000045- Dose A
Pulmonary Hypertension
Get an email about TECX's next catalysts
Track Tectonic Therapeutic (TECX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 1 more upcoming event in our data (earnings).See the timeline
2 upcoming, 1 past
TX000045- Dose A Phase 2 Est. Readout
Primary completion for TX000045- Dose A trial (NCT06616974) in Pulmonary Hypertension
SourceTECX Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-1.38 | FQ end Sep/2026 | Call: tbd
How TECX's past catalysts played out
Market Overview
Stock performance and key metrics
TX000045- Dose A
Pulmonary Hypertension
TX000045
Hypertension, Pulmonary
TX000045- Dose B
Pulmonary Hypertension
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
TX000045- Dose A | Phase 2 | Pulmonary Hypertension | - | - |
TX000045 | Phase 2 | Hypertension, Pulmonary | - | - |
TX000045- Dose B | Phase 2 | Pulmonary Hypertension | - | - |
Frequently asked questions
What is in Tectonic Therapeutic, Inc.'s drug pipeline?→
CatalystAlert tracks 3 drug candidates in Tectonic Therapeutic, Inc.'s (TECX) pipeline across Phase 2. Its lead program is TX000045- Dose A (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Tectonic Therapeutic, Inc.'s next FDA catalyst?→
Tectonic Therapeutic, Inc.'s (TECX) next tracked catalyst is a Phase 2 readout expected November 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track TECX biotech catalysts?→
Add TECX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Tectonic Therapeutic, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.